2.85
price up icon7.14%   0.19
after-market Dopo l'orario di chiusura: 2.84 -0.01 -0.35%
loading
Precedente Chiudi:
$2.66
Aprire:
$2.67
Volume 24 ore:
519.85K
Relative Volume:
1.04
Capitalizzazione di mercato:
$55.54M
Reddito:
-
Utile/perdita netta:
$-40.94M
Rapporto P/E:
-0.7422
EPS:
-3.84
Flusso di cassa netto:
$-22.97M
1 W Prestazione:
+1.42%
1M Prestazione:
-6.86%
6M Prestazione:
-42.07%
1 anno Prestazione:
-73.54%
Intervallo 1D:
Value
$2.62
$2.89
Intervallo di 1 settimana:
Value
$2.52
$2.89
Portata 52W:
Value
$1.11
$11.29

Annovis Bio Inc Stock (ANVS) Company Profile

Name
Nome
Annovis Bio Inc
Name
Telefono
484-875-3192
Name
Indirizzo
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA
Name
Dipendente
6
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-11
Name
Ultimi documenti SEC
Name
ANVS's Discussions on Twitter

Confronta ANVS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ANVS
Annovis Bio Inc
2.85 51.83M 0 -40.94M -22.97M -3.84
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Annovis Bio Inc Stock (ANVS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-10 Downgrade D. Boral Capital Buy → Hold
2024-10-25 Aggiornamento Maxim Group Hold → Buy
2023-12-29 Iniziato Canaccord Genuity Buy
2021-07-07 Reiterato Maxim Group Buy

Annovis Bio Inc Borsa (ANVS) Ultime notizie

pulisher
Jul 24, 2025

Annovis Bio Inc.’s Promising Alzheimer’s Drug Trial: Key Updates for Investors - TipRanks

Jul 24, 2025
pulisher
Jul 23, 2025

Is Annovis Bio Inc. a good long term investmentFree Consultation - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Annovis Bio Inc. stockFree Capital Allocation Plans - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Annovis Bio Inc. stock priceMassive portfolio appreciation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Annovis Bio Inc. Stock Analysis and ForecastSuperior investment outcomes - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Annovis Bio stock rating cut to hold at D. Boral Capital - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

Annovis Bio to Present Key Findings at Alzheimer’s Association International Conference - MSN

Jul 22, 2025
pulisher
Jul 18, 2025

What risks could impact Annovis Bio Inc. stock performanceCapital Growth Picks - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

Annovis Bio Inc. Advances Alzheimer’s Treatment with Buntanetap Study - TipRanks

Jul 16, 2025
pulisher
Jul 15, 2025

Why Annovis Bio Inc. stock attracts strong analyst attentionCapital Preservation Investment Ideas - newser.com

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Annovis Bio Inc. stock price move sharplyFree Popular Stock Recommendations - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Annovis Bio Inc. stock performs during market volatilityCapital Growth Picks - newser.com

Jul 15, 2025
pulisher
Jul 12, 2025

Annovis Bio's Volatility Trap: Why Risky Bets and Biotech Headwinds Spell Caution for Investors - AInvest

Jul 12, 2025
pulisher
Jul 04, 2025

Annovis Bio Advances Phase 3 Alzheimer’s Trial Amid Steady Financial Progress - MSN

Jul 04, 2025
pulisher
Jul 03, 2025

Parkinson's Disease Clinical and Non-Clinical Studies, Key - openPR.com

Jul 03, 2025
pulisher
Jun 30, 2025

Annovis Bio’s Alzheimer’s Study: A Potential Game-Changer for Investors? - TipRanks

Jun 30, 2025
pulisher
Jun 26, 2025

Annovis Bio Inc. to Showcase Alzheimer’s Research at AAIC 2025 - citybuzz -

Jun 26, 2025
pulisher
Jun 25, 2025

Annovis Bio Plunges 10.13% on Analyst Price Target Cut - AInvest

Jun 25, 2025
pulisher
Jun 24, 2025

Annovis Bio (ANVS) Stock Jumps Over 16% in Market Trading | ANVS Stock News - GuruFocus

Jun 24, 2025
pulisher
Jun 24, 2025

Annovis Bio to Host Webcast on June 24, 2025, Featuring Updates on Phase 3 AD Trial and PD Program Development - MSN

Jun 24, 2025
pulisher
Jun 23, 2025

Annovis Bio Approves Board Elections and Auditor Appointment - TipRanks

Jun 23, 2025
pulisher
Jun 22, 2025

We Think Annovis Bio (NYSE:ANVS) Needs To Drive Business Growth Carefully - Yahoo Finance

Jun 22, 2025
pulisher
Jun 20, 2025

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Gains 18-Month NYSE Compliance Window - FinancialContent

Jun 20, 2025
pulisher
Jun 19, 2025

Annovis Bio Secures NYSE Approval to Regain Compliance with Listing Standards - MSN

Jun 19, 2025
pulisher
Jun 19, 2025

Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance - The Manila Times

Jun 19, 2025
pulisher
Jun 14, 2025

10,923 Shares in Annovis Bio, Inc. (NYSE:ANVS) Bought by Two Sigma Investments LP - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

All You Need to Know About Annovis Bio (ANVS) Rating Upgrade to Buy - MSN

Jun 13, 2025
pulisher
Jun 12, 2025

HC Wainwright Has Optimistic View of Annovis Bio Q2 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Q1 Earnings Forecast for Annovis Bio Issued By HC Wainwright - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Annovis Bio, Inc. (NYSE:ANVS) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jun 10, 2025

Annovis Bio Inc Azioni (ANVS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):